Wilmington PharmaTech (“Wilmington”), a leading U.S.-based research, development, and manufacturing organization (CRDMO) ...
TEL AVIV, Israel--(BUSINESS WIRE)--Teva announced today its intention to divest its active-pharmaceutical ingredient (API) business, or "TAPI". TAPI is a global leader in the small-molecule API ...
qualified companies can utilize one or more of three established pharmaceutical manufacturing plants on the campus under a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results